TotalMarketCap

Medpace

MEDPNasdaq United StatesHealth CareBiotechnology: Commercial Physical & Biological Resarch

Market cap

$17.723 B

$633.62 -3.53%

Close of 6 Nov 2026

As of 6 Nov 2026, Medpace (MEDP) has a market capitalization of $17.7B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$2.53B

#1006 by revenue

Earnings

$451.1M

#655 by earnings

Shares outstanding

27,971,686

Latest filing cover page

P/E ratio

39.3

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →
  1. #1IqviaIQV$43.6B
  2. #2IncyteINCY$24.1B
  3. #3MedpaceMEDP$17.7B
  4. #4IconICLR$15.4B
  5. #5Charles River Laboratories InternationalCRL$15.0B

What if Medpace were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,009,481

Per share 1,593× higher

Bitcoin $1.53T

$54,621.24

Per share 86.2× higher

Apple $5.02T

$179,316.42

Per share 283× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Medpace are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.